Connect with us

Hi, what are you looking for?


Starting shots in poor nations by February hinges on vaccine suppliers — WHO

GENEVA — The World Health Organization (WHO) on Monday redoubled pleas for vaccine makers to provide coronavirus disease 2019 (COVID-19) shots to its COVAX program for poor nations, as an adviser said hopes of starting inoculations by February hinge on access to supplies.

The COVAX facility, backed by the WHO, GAVI the vaccine alliance, and the Coalition for Epidemic Preparedness Innovations, has raised $6 billion so far, and ordered 2 billion doses of COVID-19 vaccines with options on 1 billion more.

With nations including China, the United States, Israel, and others dominating early deliveries, however, the WHO fears scant remaining stockpiles could leave 92 lower- and lower-middle-income nations out in the cold when it comes to vaccinating their medical workers in the COVAX program’s initial round.

“We expect, and we have strong confidence that we should be able to begin vaccinating in February in these countries,” WHO senior adviser Bruce Aylward told a press conference on Monday.

“But we cannot do that on our own. We require the cooperation of vaccine manufacturers to prioritize deliveries to the COVAX facility,” he said.

More than 40 countries have begun vaccinating against COVID-19 with a growing number of shots, from Pfizer and BioNTech, Moderna, AstraZeneca, as well as vaccines developed in Russia and China.

“All of that vaccination, or virtually all, was in high-income or middle-income countries so far,” Mr. Aylward said. “We have got to see vaccines going into arms in lower and lower-middle-income countries.”

According to Reuters data, China has administered the most shots, at about 9 million, followed by 6.7 million in the United States and 1.8 million in Israel. 

Mr. Aylward held out optimism that limited COVAX vaccinations in poor nations could even start this month.

“But again, that requires the cooperation of a lot of other players,” he said. “Right now, we have an inequitable situation.” — Reuters

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!



By Jenina P. Ibañez, Senior Reporter PHILIPPINE MANUFACTURING activity rose to an eight-month high in November, as new orders increased for the first time...


THE NATIONAL Government’s outstanding debt swelled to P11.97 trillion as of the end of October as it offered more domestic securities, preliminary data from...


MOTORISTS experience heavy traffic along Commonwealth in Quezon City on Wednesday. — PHILIPPINE STAR/ MICHAEL VARCAS BANGKO SENTRAL ng Pilipinas (BSP) Governor Benjamin E....


THE SENATE on Wednesday approved on third and final reading the proposed P5.024-trillion national budget for 2022. Senators unanimously passed the 2022 General Appropriations...


EVERYTHING’s coming full circle from the boy from Cebu who wanted to write but ended up cooking. Myke “Tatung” Sarthou, celebrity chef, started out...


1 of 6 THE VIRTUS awards by the Hotel Sales and Marketing Association (HSMA) Philippines continues to honor professionals and institutions in hospitality: a...

You May Also Like


Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...


Ivermectin, an existing drug against parasites including head lice, has had a checkered history when it comes to treating COVID-19. The bulk of studies...


As a traditionally rigid insurance industry becomes bogged down by antiquated processes and operations, a handful of industry leaders are seeking to shake things...


Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered throughout...

Disclaimer:, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.